News
- Author:
- Susan London
Publish date: February 10, 2015
Key clinical point: Data are mixed regarding an overall survival benefit of resecting the primary tumor.
Major finding: Two studies found a halvin...
News
- Author:
- Susan London
Publish date: February 4, 2015
Key clinical point: IMM-101 appears safe and efficacious when added to gemcitabine as first-line therapy.
Major finding: Median overall survival w...
News
- Author:
- Susan London
Publish date: February 2, 2015
(Cyramza)
News
- Author:
- Susan London
Publish date: January 30, 2015
Key clinical point: Survival of patients with metastatic colorectal cancer in the real world falls short of that in clinical trials.
Major finding...
News
- Author:
- Susan London
Publish date: January 30, 2015
Key clinical point: Pretreatment AFP levels may be a biomarker for ramucirumab benefit.
Major finding: Patients with AFP levels of 400 ng/mL or hi...
News
- Author:
- Susan London
Publish date: January 29, 2015
Key clinical point: Patients with colorectal cancer who take statins are less likely to die.
Major finding: Relative to nonusers, statin users had...
News
- Author:
- Susan London
Publish date: January 28, 2015
Key clinical point: Characteristics of phase III trials in metastatic colorectal cancer have shifted over the past 3 decades, particularly an incr...
News
- Author:
- Susan London
Publish date: January 23, 2015
Key clinical point: Laparoscopic distal gastrectomy has less morbidity than does open distal gastrectomy.
Major finding: Patients in the laparosco...
News
- Author:
- Susan London
Publish date: January 21, 2015
Key clinical point: The combination of MM-398 plus 5-FU/LV was superior to 5-FU/LV alone.
Major finding: Median overall survival was 6.1 months wi...
News
- Author:
- Susan London
Publish date: January 21, 2015
Key clinical point: Famitinib is active and has manageable toxicity in patients with metastatic colorectal cancer.
Major finding: Median progressi...
News
- Author:
- Susan London
Publish date: January 20, 2015
Key clinical point: Preoperative arterial chemotherapy improves outcomes, but mainly for stage III patients.
Major finding: Five-year disease-free...
News
- Author:
- Susan London
Publish date: January 19, 2015
Key clinical point: AMG 337 promoted tumor regression in patients with MET-amplified esophagogastric cancers.
Major finding: The response rate was...
News
- Author:
- Susan London
Publish date: January 17, 2015
Key clinical point: Patients with higher 25-hydroxyvitamin D levels had better progression-free and overall survival.
Major finding: Median surviv...
News
- Author:
- Susan London
Publish date: January 13, 2015
Key clinical point: Adding ramucirumab to second-line chemotherapy delayed progression and prolonged survival, with manageable toxicity.
Major fin...
News
- Author:
- Susan London
Publish date: January 13, 2015
Key clinical point: Patients with rectal cancer who have a clinical complete response to neoadjuvant therapy can safely skip surgery.
Major findin...
